Send me a link:

*Text messaging rates may apply.

 Dow Down0.42% Nasdaq Down0.05%

Progenics Pharmaceuticals, Inc. (PGNX)

-NasdaqGS
5.03 Up 0.04(0.80%) 4:00PM EDT
|After Hours : 5.03 0.00 (0.00%) 4:31PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.0
Mean Recommendation (last week):2.0
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:9.50
Median Target:9.50
High Target:11.00
Low Target:8.00
No. of Brokers:2

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Feb 3, 2014NeedhamUpgradeHoldBuy
Aug 30, 2012Stifel NicolausInitiated Hold
Jul 30, 2012NeedhamDowngradeBuyHold
Feb 10, 2011Brean MurrayUpgradeHoldBuy
Mar 16, 2009OppenheimerDowngradeOutperformPerform
Mar 16, 2009Brean MurrayDowngradeBuyHold
Mar 12, 2009FTN Equity CapitalInitiated Neutral
Jul 2, 2008Friedman BillingsDowngradeMkt PerformUnderperform
Apr 25, 2008CitigroupUpgradeSellHold
Mar 12, 2008Lazard CapitalDowngradeBuyHold

More Upgrades & Downgrades for PGNX

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy1111
Buy1111
Hold1111
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.